Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec:18:103-105.
doi: 10.1016/j.jdcr.2021.10.007. Epub 2021 Oct 20.

Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2

C Yoonhee Ryder  1 , Elisabeth A Pedersen  1 , Jennifer B Mancuso  1
Affiliations
Case Reports

Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2

C Yoonhee Ryder et al. JAAD Case Rep. 2021 Dec.
No abstract available

Keywords: COVID-19; Ig, Immunoglobulin; MIRM; MIRM, mycoplasma-induced rash and mucositis; PCR, polymerase chain reaction; RIME; RIME, reactive infectious mucocutaneous eruption; SARS-CoV-2; cyclosporine; mucositis.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Erosive plaques (9 days following diagnosis of COVID-19) (A); hemorrhagic plaques and crusts on the oral, nasal, and urethral mucosa (17 days following diagnosis of COVID-19) (B) and complete resolution (26 days following diagnosis of COVID-19) (C).
See this image and copyright information in PMC

References

    1. Rekhtman S., Tannenbaum R., Strunk A., Birabaharan M., Wright S., Garg A. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children. J Am Acad Dermatol. 2021;84(2):408–414. - PMC - PubMed
    1. Bitar C., Chan M.P., Harms P.W., et al. Cutaneous manifestations of hospitalized coronavirus disease 2019 patients: a report of six cases with clinicopathologic features and viral RNA in situ hybridization. J Eur Acad Dermatol Venereol. 2020;34(11):e656–e659. - PMC - PubMed
    1. Iranmanesh B., Khalili M., Amiri R., Zartab H., Aflatoonian M. Oral manifestations of COVID-19 disease: a review article. Dermatol Ther. 2021;34(1):e14578. - PMC - PubMed
    1. Nuño González A., Magaletskyy K., Martín Carrillo P., et al. Are oral mucosal changes a sign of COVID-19? A cross-sectional study at a field Hospital. Actas Dermosifiliogr. 2021;112(7):640–644. - PMC - PubMed
    1. Meyer Sauteur P.M., Theiler M., Buettcher M., Seiler M., Weibel L., Berger C. Frequency and clinical presentation of mucocutaneous disease due to Mycoplasma pneumoniae infection in children with community-acquired pneumonia. JAMA Dermatol. 2020;156(2):144–150. - PMC - PubMed

Publication types